Novel Drug Delivery Modalities

Novel drug delivery technologies

IriSys develops formulations for new chemical entities and ANDA/generic products. We also have experience developing formulations with 505(b)(2) product candidates, which can rely in part on data from existing reference drugs. Our formulations can support the expansion of our clients’ intellectual property portfolios.

Micronization technologies

Micro and nanoparticles

Encapsulation technologies

Liposomes, microspheres and micelles

Controlled release formulations

Controlled release solid dosages